Dr. Brian C. Mccormick, M.D.
Family Medicine (Family Medicine Physician)
9 Manhattan Sq, Suite A
Hampton, VA 23666
Who else practices at this address →
Hampton city is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Eastern Virginia Medical School (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 571
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: Eastern Virginia Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
VA license 0101049100
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
- Riverside Regional Medical Center Newport News, VA
- Sentara Careplex Hospital Hampton, VA
- Sentara Williamsburg Regional Medical Center Williamsburg, VA
- Mary Immaculate Hospital Newport News, VA
Medical groups
- Aspire MDvip LLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 571
- Services billed
- 6,174
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,072 | 473 |
| Insertion of needle into vein for collection of blood sample | 867 | 450 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 455 | 352 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 302 | 302 |
| Administration of influenza virus vaccine | 238 | 231 |
| Influenza vaccine split virus, preservative free | 230 | 223 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | 219 |
| Annual depression screening, 5 to 15 minutes | 188 | 188 |
| Established patient office or other outpatient visit, 20-29 minutes | 162 | 127 |
| Established patient office or other outpatient visit, 40-54 minutes | 160 | 115 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $49,050 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
Sanofi US Services Inc. · Completed · NCT06181435 - A phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like part…
AstraZeneca Pharmaceuticals LP - Lum004
Lumiradx, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.